Golimumab reduces spinal inflammation in ankylosing spondylitis: MRI results of the randomised, placebo- controlled GO-RAISE study

OBJECTIVE: To evaluate golimumab's effect on MRI-detected spinal inflammation in ankylosing spondylitis (AS). METHODS: Patients were randomly assigned to subcutaneous injections of placebo (n=78), golimumab 50 mg (n=138), or golimumab 100 mg (n=140) every 4 weeks. An MRI substudy comprising 98...

Descripción completa

Detalles Bibliográficos
Autores principales: Braun, Jürgen, Baraliakos, Xenofon, Hermann, Kay-Geert A, van der Heijde, Désirée, Inman, Robert D, Deodhar, Atul A, Baratelle, Anna, Xu, Stephen, Xu, Weichun, Hsu, Benjamin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371220/
https://www.ncbi.nlm.nih.gov/pubmed/22128083
http://dx.doi.org/10.1136/annrheumdis-2011-200308

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3371220/
https://www.ncbi.nlm.nih.gov/pubmed/22128083
http://dx.doi.org/10.1136/annrheumdis-2011-200308

Ejemplares similares